FR2128267A1 - Anti-cancer medicament - contg mumps viruses from saliva of patients - Google Patents

Anti-cancer medicament - contg mumps viruses from saliva of patients

Info

Publication number
FR2128267A1
FR2128267A1 FR7129864A FR7129864A FR2128267A1 FR 2128267 A1 FR2128267 A1 FR 2128267A1 FR 7129864 A FR7129864 A FR 7129864A FR 7129864 A FR7129864 A FR 7129864A FR 2128267 A1 FR2128267 A1 FR 2128267A1
Authority
FR
France
Prior art keywords
saliva
patients
contg
mumps
cancer medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7129864A
Other languages
French (fr)
Other versions
FR2128267B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASADA TERUO JA
Original Assignee
ASADA TERUO JA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASADA TERUO JA filed Critical ASADA TERUO JA
Publication of FR2128267A1 publication Critical patent/FR2128267A1/en
Application granted granted Critical
Publication of FR2128267B1 publication Critical patent/FR2128267B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Mumps viruses selectively destroy rapidly propagating cells. The medicament is used orally and is non-toxic. Prepd. from the saliva of mumps-patients in the first stage of infection by mixing with equiv. amts of glycerol + saline, freeing from saprophytes by treatment with antibiotics and preserving with germicides at low temps.
FR7129864A 1971-03-09 1971-08-16 Anti-cancer medicament - contg mumps viruses from saliva of patients Granted FR2128267A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1258771 1971-03-09

Publications (2)

Publication Number Publication Date
FR2128267A1 true FR2128267A1 (en) 1972-10-20
FR2128267B1 FR2128267B1 (en) 1975-02-07

Family

ID=11809473

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7129864A Granted FR2128267A1 (en) 1971-03-09 1971-08-16 Anti-cancer medicament - contg mumps viruses from saliva of patients

Country Status (4)

Country Link
DE (1) DE2154202A1 (en)
DK (1) DK127457B (en)
FR (1) FR2128267A1 (en)
NL (1) NL7111160A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003733A1 (en) * 1998-07-16 2000-01-27 Vincent Marinkovich Methods and compositions for cancer treatment

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1314431E (en) 1993-04-30 2008-10-24 Wellstat Biologics Corp Purified compositions of newcastle disease virus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000003733A1 (en) * 1998-07-16 2000-01-27 Vincent Marinkovich Methods and compositions for cancer treatment

Also Published As

Publication number Publication date
DE2154202A1 (en) 1972-09-14
DK127457B (en) 1973-11-12
NL7111160A (en) 1972-09-12
FR2128267B1 (en) 1975-02-07

Similar Documents

Publication Publication Date Title
CA1005304A (en) Integral blood oxygenator and heat exchanger
GB1213004A (en) Improved surgical drainage apparatus
BE770323A (en) PANCREATIN PREPARATION, WITHOUT GERMS AND EASILY FLOWING AND PROCEDURE FOR ITS PREPARATION
ATA1054472A (en) VALVE FOR DENTAL HANDPIECES, FOR EXAMPLE FOR DRILLING, INJECTION AND SUCTION HANDPIECES
IT946151B (en) DIALYZER IN PARTICULAR FOR THE PURIFICATION OF BLOOD
AU458386B2 (en) Improvements in or relating tothe treatment of diseases ofthe skin and mucosa
AU470383B2 (en) Hemodialyzer with tapered slip blood ports and baffles
ZA733736B (en) And medical purposes improvements in or relating to tubes for surgical
ES8504459A1 (en) Transfer factor for use in treating viral infections.
FR2128267A1 (en) Anti-cancer medicament - contg mumps viruses from saliva of patients
FR2134292A1 (en) Interferon compsns - contg halo desoxyuridines rifamycine or rifampycine
AT317607B (en) Agent for combating and preventing the growth of algae and microorganisms in aqueous systems
IT1057861B (en) COMPOSITION FOR DIAGNOSIS AND TREATMENT OF MICROBIAL INFECTIONS
JPS521352A (en) Buffer body of shaft coupling
OA04927A (en) New Amino-propanediol derivatives, their preparation process and their applications in human therapy.
Bailey Plasma calcium and blood pressure in the American eel, anguilla rostrata Lesueur, with particular emphasis on the role of the corpuscles of Stannius.
Kleinsasser Solitary pyogenic abscess of the left lobe of the liver
SE404990B (en) PROCEDURE FOR PRESERVING HUMAN BLOOD AND CONSERVING SOLUTION FOR PERFORMING THE PROCEDURE
TAMAI et al. Studies on tissue concentration of antibiotics in the field dental and oral surgery V. Basic experiment on concentration of carbenicillin in the jaw bone
KARAMCHANDANI et al. or alternatively pus cells comparatively more
Olivo et al. Malignancy-associated Sweet's syndrome: Review of the world literature
BROWN et al. RECURRENT INFECTIOUS PAROTITIS: REPORT OF A CASE IN A CHILD FIVE YEARS OLD
BE757336A (en) 5-butyl-and5-pentyl-picolinic acids active - as dopamene-b-hydroxylase inhibitors
Del Guercio Advances in physiologic sensing
OSAKI et al. Report of a case of tuberculous lymphadenitis

Legal Events

Date Code Title Description
ST Notification of lapse